% Expired Patents = 75.0

Forward Citations = 50

Loading Chart...

7 inventors (with patents filed for the assignee):

Dennis J Flood (4 out of 15 patents)

Andrew Ross Barron (3 out of 48 patents)

Elizabeth Whitsitt (1 out of 17 patents)

4. Robin E Anderson (1 out of 2 patents)

5. Graham B I Scott (1 out of 4 patents)

6. Andrew A Guzelian (1 out of 1 patent)

7. John Ryan Loscutova (1 out of 18 patents)

4 patents: Sort by Forward Citations

1. 8433417 - Carbon nanostructure artificial retinal implant (2013-04-30),

2. 7692218 - Method for creating a functional interface between a nanoparticle, nanotube or nanowire, and a biological molecule or system (2010-04-06),

3. 7491376 - Chemical derivatization of silica coated fullerenes and use of derivatized silica coated fullerenes (2009-02-17),

4. 7253014 - Fabrication of light emitting film coated fullerenes and their application for in-vivo light emission (2007-08-07),

Company Overview

Newcyte, Inc. is a biotechnology company specializing in cell therapy solutions. With a focus on regenerative medicine, Newcyte develops innovative therapies for various medical conditions. Their cutting-edge technology and research have led to advancements in cell-based treatments, offering hope for patients with chronic diseases and injuries.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#14 in Sudbury, MA

#3,314 in Massachusetts

#60,671 in US

Sudbury, MA, United States of America

Newcyte, Inc.

Forward Citations = 50

7 inventors:

Dennis J Flood (4 out of 15 patents)

Andrew Ross Barron (3 out of 48 patents)

Elizabeth Whitsitt (1 out of 17 patents)

4. Robin E Anderson (1 out of 2 patents)

5. Graham B I Scott (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Newcyte, Inc.. Retrieved from https://idiyas.com/company/newcyte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]